Goldman Sachs Group Reaffirms “Sell” Rating for Spectris (LON:SXS)

Share on StockTwits

Goldman Sachs Group restated their sell rating on shares of Spectris (LON:SXS) in a research note released on Wednesday, ThisIsMoney.Co.Uk reports.

A number of other equities analysts have also commented on SXS. Bank of America upgraded Atlas Copco from a neutral rating to a buy rating in a research note on Friday, July 5th. Deutsche Bank set a $261.00 price objective on Vail Resorts and gave the stock a buy rating in a research note on Friday, June 7th. UBS Group restated a buy rating and set a GBX 285 ($3.72) price objective on shares of in a research note on Friday, June 21st. Peel Hunt restated a buy rating on shares of Lookers in a research note on Monday, July 8th. Finally, Numis Securities restated a buy rating on shares of 3i Group in a research note on Thursday, May 16th. Three analysts have rated the stock with a sell rating, seven have issued a hold rating and four have given a buy rating to the company. Spectris currently has an average rating of Hold and a consensus price target of GBX 2,685.45 ($35.09).

Spectris stock opened at GBX 2,658 ($34.73) on Wednesday. The business’s fifty day moving average is GBX 2,678.66. Spectris has a one year low of GBX 1,924.50 ($25.15) and a one year high of GBX 2,932 ($38.31). The company has a debt-to-equity ratio of 30.03, a quick ratio of 1.03 and a current ratio of 1.60. The company has a market cap of $3.08 billion and a price-to-earnings ratio of 16.94.

About Spectris

Spectris plc manufactures and sells measuring instruments and controls worldwide. It operates through four segments: Materials Analysis, Test and Measurement, In-line Instrumentation, and Industrial Controls. The Materials Analysis segment provides products and services, which enable customers to determine structure, composition, quantity, and quality of particles and materials during their research and development processes, when assessing materials before production, or during the manufacturing process.

Further Reading: What Are Cryptocurrencies?

Analyst Recommendations for Spectris (LON:SXS)

Receive News & Ratings for Spectris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spectris and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


 
© 2006-2019 BBNS.